These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3255492)

  • 21. Homozygous familial hypercholesterolaemia presenting with cutaneous xanthomas: response to liver transplantation.
    Moyle M; Tate B
    Australas J Dermatol; 2004 Nov; 45(4):226-8. PubMed ID: 15527434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
    Miltiadous G; Cariolou MA; Elisaf M
    Ann Clin Lab Sci; 2002; 32(1):50-4. PubMed ID: 11848618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Daniels SR; Gidding SS; de Ferranti SD;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527
    [No Abstract]   [Full Text] [Related]  

  • 24. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract]   [Full Text] [Related]  

  • 25. [Perspectives in familial hypercholesterolemia: with particular reference to associated ischemic heart disease].
    Miida T; Aizawa Y; Yamazoe M; Shibata A
    J Cardiol; 1988 Dec; 18(4):1007-13. PubMed ID: 3267710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic and functional significance of arcus lipoides in hypercholesterolemia].
    Schneider T; Ulbig M
    Fortschr Ophthalmol; 1991; 88(1):21-4. PubMed ID: 2045021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject.
    Ketomaki A; Gylling H; Miettinen TA
    J Lab Clin Med; 2004 Apr; 143(4):255-62. PubMed ID: 15085084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive lipid lowering treatment in coronary atherosclerosis.
    Stalenhoef AF; Kroon AA; Aengevaeren WR
    Cardiologia; 1997 Sep; 42(9):935-40. PubMed ID: 9369038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated levels of lipoprotein (a) in children with familial hypercholesterolemia.
    Widhalm K; Genser D
    Wien Klin Wochenschr; 1994; 106(7):197-200. PubMed ID: 8197753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk factors for atherosclerosis in childhood. Evaluation of total blood cholesterol and triglycerides in children of parents with myocardial infarction before age 45].
    Biadaioli R; Bertini G; De Martino M; Appendino C; Pratesi F; Vierucci A
    Minerva Pediatr; 1982 Sep; 34(17):683-9. PubMed ID: 6755210
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical manifestations of heterozygote familial hypercholesterolemia in Spain. Study of 301 cases from the central and northern areas].
    Garcés C; Rodríguez Artalejo F; Serrano A; González Bonillo J; Almagro F; Garrido JA; Zúñiga M; de Oya M
    Med Clin (Barc); 2000 Jan; 114(2):50-1. PubMed ID: 10702948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid profile in familial hypercholesterolaemia.
    Gomo Z
    Cent Afr J Med; 1993 Nov; 39(11):228-31. PubMed ID: 8055553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The RED-LIP study--pravastatin in primary isolated hypercholesterolemia--an open, prospective, multicenter trial.
    Sinzinger H; Pirich C
    Wien Klin Wochenschr; 1994; 106(23):721-7. PubMed ID: 7856175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early and late results of coronary artery bypass in patients with hyperlipoproteinemia.
    Hanson EC; Levine FH; Adzick NS; Lees RS; Daggett WM; Austen WG; Buckley MJ
    J Thorac Cardiovasc Surg; 1980 Mar; 79(3):372-80. PubMed ID: 6965512
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sporadic type IIa hyperlipoproteinemia in a 10-year-old girl without familial appearance. Description of a case].
    Joven J; Ordi J; Rubiés-Prat J; Vilardell M; Masdeu S
    Med Clin (Barc); 1984 Jun; 83(2):71-3. PubMed ID: 6471947
    [No Abstract]   [Full Text] [Related]  

  • 37. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease.
    Castillo S; Reyes G; Tejedor D; Mozas P; Suarez Y; Lasuncion MA; Cenarro A; Civeira F; Alonso R; Mata P; Pocovi M;
    Hum Mutat; 2002 Dec; 20(6):477. PubMed ID: 12442279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reverse cholestrol transport substantially influences the individual risk of coronary heart disease in hypercholesterolaemic patients.
    Poledne R; Rosolová H
    Eur Heart J; 2001 Mar; 22(6):442-3. PubMed ID: 11237535
    [No Abstract]   [Full Text] [Related]  

  • 39. [Induracin, prolonged-action nicotinic acid, in the treatment of atherogenic dyslipoproteinemia].
    Kiseleva NG
    Klin Med (Mosk); 1994; 72(3):20-4. PubMed ID: 7990345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of selective LDL-removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption system.
    Yamamoto A; Yokoyama S; Satani M; Kikkawa T; Kishino B
    Prog Clin Biol Res; 1988; 255():357-66. PubMed ID: 3340645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.